|
ZNF565 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65739999502534E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.73279998419929E-09 |
| Normal-vs-Stage2 |
1.203380E-03 |
| Normal-vs-Stage3 |
6.959800E-04 |
| Normal-vs-Stage4 |
8.364100E-03 |
| Stage1-vs-Stage2 |
7.697600E-01 |
| Stage1-vs-Stage3 |
1.295770E-01 |
| Stage1-vs-Stage4 |
1.047960E-01 |
| Stage2-vs-Stage3 |
2.526000E-01 |
| Stage2-vs-Stage4 |
1.831590E-01 |
| Stage3-vs-Stage4 |
7.790600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.00810000031638E-08 |
| Normal-vs-AfricanAmerican |
1.860650E-03 |
| Normal-vs-Asian |
2.548100E-02 |
| Caucasian-vs-AfricanAmerican |
6.990400E-01 |
| Caucasian-vs-Asian |
7.562000E-02 |
| AfricanAmerican-vs-Asian |
1.627820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.28849999961822E-07 |
| Normal-vs-Female |
5.61249999808666E-08 |
| Male-vs-Female |
2.828000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.575200E-03 |
| Normal-vs-Age(41-60Yrs) |
5.9853999978543E-08 |
| Normal-vs-Age(61-80Yrs) |
4.42789999999249E-06 |
| Normal-vs-Age(81-100Yrs) |
1.759040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.277400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.030960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.329380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.182800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.780000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.058000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.501600E-03 |
| Normal-vs-Grade 2 |
2.41810016454735E-10 |
| Normal-vs-Grade 3 |
2.588700E-04 |
| Normal-vs-Grade 4 |
1.909510E-02 |
| Grade 1-vs-Grade 2 |
3.791000E-01 |
| Grade 1-vs-Grade 3 |
6.281600E-02 |
| Grade 1-vs-Grade 4 |
6.052300E-02 |
| Grade 2-vs-Grade 3 |
6.042400E-03 |
| Grade 2-vs-Grade 4 |
2.254300E-02 |
| Grade 3-vs-Grade 4 |
7.557800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.10020051034144E-10 |
| Normal-vs-ccB subtype |
1.015020E-04 |
| ccA subtype-vs-ccB subtype |
6.524300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46660000002841E-06 |
| Normal-vs-N1 |
8.043900E-02 |
| N0-vs-N1 |
5.156000E-01 |
|
|
